Merkel cell polyomavirus infection and Merkel cell carcinoma in HIV-positive individuals

Area of Science:

• Oncology
• Virology
• Dermatology

Background:

• Merkel cell carcinoma (MCC) is an aggressive skin cancer with rising incidence.
• Merkel cell polyomavirus (MCPyV) is a recently identified cause of MCC.
• HIV-infected individuals have an elevated risk for developing MCC.

Purpose of the Study:

• To review the role of MCPyV in MCC development, particularly in HIV-infected individuals.
• To highlight the increased prevalence and viral load of MCPyV in immunocompromised populations.
• To discuss implications for MCC screening and management in HIV patients.

Main Methods:

• Review of recent studies on MCPyV and MCC.
• Analysis of MCPyV prevalence and DNA detection in various body sites.
• Comparison of MCPyV status between HIV-infected individuals and healthy controls.

Main Results:

• MCPyV is present in approximately 80% of MCC cases, often integrated into the host genome.
• MCPyV infection is common in the general population, acquired early in life.
• HIV-infected individuals show increased MCPyV prevalence and higher cutaneous viral loads, especially with severe immunosuppression.
• MCC in HIV patients often occurs at a younger age and on non-sun-exposed skin.

Conclusions:

• The causal role of MCPyV in MCC development is supported by current evidence.
• Elevated MCPyV loads in HIV-infected individuals may contribute to their increased MCC risk.
• Development of screening and early detection guidelines for MCC in HIV-positive patients is recommended.
• Further research should investigate MCC incidence trends in HIV patients and the impact of antiretroviral therapy on MCPyV load and MCC risk.